Furthermore, findings from TCGA, GEO, and the validation cohort demonstrated that individuals with greater levels of BANF1 in HNSCC had a diminished overall life expectancy compared to those with lower levels of BANF1. This evidence concerns the gene BANF1 and head and neck squamous cell carcinoma.